Drug infusion system with graphical user interface

Abstract

A drug infusion system with a graphical user interface, comprising: a detection device (100) for detecting a blood glucose level of a user; the infusion device (102) is used for infusing medicine into the body of the user; and a control device (101), the control device (101) being in wireless communication with the detection device (100) and the infusion device (102), the control device (101) controlling drug delivery of the infusion device (102), the control device (101) being provided with a graphical user interface, the graphical user interface comprising a main screen, the main screen comprising an insulin information display area and a blood glucose information display area, the insulin information display area comprises insulin infusion state information, and the user interface displays the insulin infusion state information in a graph (2021) and / or text (2022) mode, so that a user can intuitively know the current insulin infusion state information and blood glucose information.

Description

Drug infusion system with graphical user interface Technical Field

[0001] The present invention mainly relates to the field of medical devices, and in particular to a drug infusion system with a graphical user interface. Background Art

[0002] In a healthy individual, the pancreas automatically secretes insulin and glucagon based on blood glucose levels, maintaining a healthy blood sugar range. However, in diabetics, pancreatic function is abnormal, preventing the body from producing the necessary insulin. Diabetes is a metabolic disease, a lifelong condition. Current medical technology cannot cure diabetes; instead, it can control the onset and progression of diabetes and its complications by stabilizing blood sugar levels.

[0003] Diabetic patients need to test their blood sugar before injecting insulin into their bodies. Current detection methods can continuously detect blood sugar and send blood sugar data to a display device in real time for users to view. This detection method is called continuous glucose monitoring (CGM). This method requires the detection device to be attached to the surface of the skin, and the probe it carries is inserted into the subcutaneous tissue fluid to complete the detection. Based on the blood sugar value detected by CGM, the control device calculates the amount of insulin required in the current or future period, and the infusion device injects insulin into the subcutaneous tissue according to the insulin infusion strategy input by the control device or the user, thereby forming a closed-loop or semi-closed-loop artificial pancreas.

[0004] Currently, due to the trend of miniaturization of devices, the area on the infusion device and / or control device used to display blood sugar or insulin information, or the area for user input, is getting smaller and smaller. As a result, the user cannot intuitively understand the insulin infusion status information and / or blood sugar information that they need to pay attention to, and the user cannot operate independently and conveniently, resulting in a poor user experience.

[0005] Therefore, the prior art urgently needs a drug infusion system for displaying drug infusion information, which facilitates users to understand insulin infusion status information.

[0006] Summary of the Invention

[0007] An embodiment of the present invention discloses a drug infusion system with a graphical user interface, including a detection device, an infusion device and a control device. The control device has a graphical user interface. The user interface includes a main screen, which includes an insulin information display area and a blood glucose information display area. The insulin information display area includes insulin infusion status information. The user interface displays the insulin infusion status information in the form of graphics and / or text, making it easy for the user to intuitively understand the current insulin infusion status information and blood glucose information.

[0008] The present invention discloses a drug infusion system with a graphical user interface, comprising: a detection device, the detection device is used to detect the user's blood sugar level; an infusion device is used to infuse drugs into the user's body; and a control device, the control device wirelessly communicates with the detection device and the infusion device, and the control device controls the drug delivery of the infusion device. The control device has a graphical user interface, and the graphical user interface includes a main screen, the main screen includes an insulin information display area and a blood sugar information display area, the insulin information display area includes insulin infusion status information, and the graphical user interface displays the insulin infusion status information in the form of graphics and / or text.

[0009] According to one aspect of the present invention, the graphic is a circle with at least one color, indicating the infusion type and progress of insulin infusion, and the text includes an abbreviation of the infusion type and the infusion rate or infusion progress.

[0010] According to one aspect of the present invention, the blood glucose information display area includes a blood glucose graph display area and a detection device status display area.

[0011] According to one aspect of the present invention, the detection device status display area is arranged in a circular ring.

[0012] According to one aspect of the present invention, the detection device status display area displays information indicating whether the detection device is in a general detection status or a special detection status.

[0013] According to one aspect of the present invention, when the detection device is in a normal detection state, the detection device state display area displays the most recent blood glucose reading.

[0014] According to one aspect of the present invention, when the detection device is in a special detection state, the detection device state display area displays text information with specific meaning to remind the user that there is an abnormality in the detection device or the blood sugar value detected by the detection device.

[0015] According to one aspect of the present invention, the blood glucose graphic display area includes a blood glucose reading curve or discrete blood glucose reading points over a period of time, and a normal blood glucose value area or standard lines for high and low blood glucose values.

[0016] According to one aspect of the present invention, when the detection device is in a general detection state, the detection device state display area further includes a blood glucose trend display area.

[0017] According to one aspect of the present invention, the blood sugar trend display area is represented by indicating arrows with different numbers, directions and colors.

[0018] According to one aspect of the present invention, the blood sugar trend display area is arranged in a circular ring.

[0019] According to one aspect of the present invention, the main screen further includes a detection device calibration display area.

[0020] According to one aspect of the present invention, the quasi-display area changes over time to dynamically display the calibration status of the detection device.

[0021] According to one aspect of the present invention, the main screen further includes a blood glucose recovery data icon, which appears during the blood glucose data recovery period and disappears after the blood glucose data is fully recovered.

[0022] According to one aspect of the present invention, the screen further includes an infusion pause function icon for displaying the status of a hypoglycemia infusion pause function or a predicted hypoglycemia infusion pause function in the drug infusion system.

[0023] According to one aspect of the present invention, the home screen further includes an alarm status icon.

[0024] According to one aspect of the present invention, the detection device and the infusion device are respectively arranged in different structures.

[0025] According to one aspect of the present invention, the detection device and the infusion device are respectively arranged in the same structure.

[0026] The present invention also discloses a drug infusion system with a graphical user interface, comprising: a detection device, the detection device is used to detect the user's blood sugar level; an infusion device is used to infuse drugs into the user's body; and a control device, the control device wirelessly communicates with the detection device and the infusion device, and the control device controls the drug delivery of the infusion device. The control device has a graphical user interface, and the graphical user interface includes a main screen, which includes an insulin information display area and a blood sugar information display area. The main screen can enter other different interfaces in a sliding manner.

[0027] According to one aspect of the present invention, the sliding method includes a sliding direction and / or a sliding number, and sliding in different directions and / or sliding numbers causes the main screen to enter other different interfaces.

[0028] According to one aspect of the present invention, the graphical user interface returns to the main screen from other different interfaces by sliding.

[0029] According to one aspect of the present invention, the sliding manner for entering other different interfaces is related to the sliding manner for returning to the home screen from other different interfaces.

[0030] According to one aspect of the present invention, the sliding direction of entering another different interface and the sliding direction of returning to the main screen from another different interface are opposite, and the number of sliding times is the same.

[0031] According to one aspect of the present invention, the graphical user interface returns to the home screen from any other interface in a unified manner.

[0032] According to one aspect of the present invention, a touch-sensitive button is provided on the user interface, and the unified method is to return to the home screen through the touch-sensitive button.

[0033] According to one aspect of the present invention, a unified way is to return to the home screen by continuously tapping the user interface.

[0034] According to one aspect of the present invention, a unified approach is to return to the home screen in a specific sliding direction and number of times.

[0035] According to one aspect of the present invention, the control device further includes a physical button, and the unified method is to return to the home screen via the physical button.

[0036] According to one aspect of the present invention, the insulin information display area includes insulin infusion status information, information on the amount of insulin IOB that has not yet taken effect in the body, and information on the remaining amount of insulin in the infusion device. The graphical user interface displays the insulin infusion status information in graphical and / or textual form.

[0037] According to one aspect of the present invention, the blood glucose information display area includes a blood glucose graph display area and a detection device status display area.

[0038] According to one aspect of the present invention, the detection device status display area can display information indicating whether the detection device is in a general detection status or a special detection status.

[0039] According to one aspect of the present invention, the blood glucose graphic display area includes a blood glucose reading curve or discrete blood glucose reading points over a period of time, and a normal blood glucose value area or standard lines for high and low blood glucose values.

[0040] According to one aspect of the present invention, when the detection device is in a general detection state, the detection device state display area further includes a blood glucose trend display area.

[0041] According to one aspect of the present invention, the main screen further includes a detection device calibration display area.

[0042] According to one aspect of the present invention, the main screen further includes a blood glucose recovery data icon, which appears during the blood glucose data recovery period and disappears after the blood glucose data is fully recovered.

[0043] According to one aspect of the present invention, the screen further includes an infusion pause function icon for displaying the status of a hypoglycemia infusion pause function or a predicted hypoglycemia infusion pause function in the drug infusion system.

[0044] According to one aspect of the present invention, the home screen further includes an alarm status icon.

[0045] The present invention also discloses a drug infusion system with a graphical user interface, comprising: a detection device, the detection device is used to detect the user's blood sugar value; an infusion device is used to infuse drugs into the user's body; and a control device, the control device wirelessly communicates with the detection device and the infusion device, the control device controls the drug delivery of the infusion device, the control device has a graphical user interface, the graphical user interface includes a main screen, the main screen includes an insulin information display area and a blood sugar information display area, the insulin information display area includes insulin infusion status information, the blood sugar information display area includes a blood sugar graphic display area, which graphically displays the user's blood sugar level in a first time period, and through user input, the graphical user interface displays the user's blood sugar level in other time periods.

[0046] According to one aspect of the present invention, blood glucose levels during other time periods are displayed on the main screen.

[0047] According to one aspect of the present invention, through user input, a time period selection area is displayed on the main screen, and a different time period is selected, and the blood glucose graph display area displays the blood glucose level within the same time period.

[0048] According to one aspect of the present invention, blood glucose levels in other time periods are displayed in the expanded blood glucose graphic display area.

[0049] According to one aspect of the present invention, the expanded blood glucose graph display area at least partially covers the main screen.

[0050] According to one aspect of the present invention, the expanded blood glucose graph display area includes at least a time period selection area and a blood glucose graph display area.

[0051] According to one aspect of the present invention, the expanded blood glucose graphic display area further includes a blood glucose text display area for displaying blood glucose value information or special detection status information at a selected moment.

[0052] According to one aspect of the present invention, in response to another user input, the blood glucose graphic display area displays blood glucose value information or special detection status information at a selected moment.

[0053] According to one aspect of the present invention, the blood glucose graphic display area further includes an event indication mark for indicating the time when an event occurs.

[0054] According to one aspect of the present invention, the detailed blood glucose information interface is entered from the blood glucose graphic display area through another user input.

[0055] According to one aspect of the present invention, the detailed blood glucose information interface includes at least basic statistical data and / or distribution statistical data.

[0056] According to one aspect of the present invention, the blood sugar information display area further includes a detection device status display area.

[0057] According to one aspect of the present invention, the detection device status display area is used to display information indicating whether the detection device is in a general detection state or a special detection state.

[0058] According to one aspect of the present invention, when the detection device is in a normal detection state, the detection device state display area displays the blood glucose reading at the most recent moment.

[0059] According to one aspect of the present invention, when the detection device is in a special detection state, the detection device state display area displays text information with specific meaning to remind the user that there is an abnormality in the detection device or the blood sugar value detected by the detection device.

[0060] According to one aspect of the present invention, the user interface displays the insulin infusion status information in a graphical and / or textual manner.

[0061] According to one aspect of the present invention, the graphic is a circle with at least one color, indicating the infusion type and progress of insulin infusion, and the text includes an abbreviation of the infusion type and the infusion rate or infusion progress.

[0062] According to one aspect of the present invention, the detection device status display area is arranged within the circular ring.

[0063] According to one aspect of the present invention, when the detection device is in a general detection state, the detection device state display area further includes a blood glucose trend display area.

[0064] According to one aspect of the present invention, the blood sugar trend display area is represented by indicating arrows with different numbers, directions and colors.

[0065] The present invention also discloses a drug infusion system for displaying drug infusion information, comprising: an infusion device for infusing drugs into a user's body; and a control device, the control device wirelessly communicating with the infusion device, the control device controlling the drug delivery of the infusion device, the control device having a graphical user interface, the graphical user interface including a main screen, the main screen including insulin infusion status information, the user interface displaying the insulin infusion status information in the form of graphics and / or text.

[0066] According to one aspect of the present invention, the graphic is a circle with at least one color, indicating the infusion type and progress of insulin infusion, and the text includes an abbreviation of the infusion type and the infusion rate or infusion progress.

[0067] According to one aspect of the present invention, when the infusion device is in a special state, the insulin infusion state information is displayed as text information with a specific meaning to remind the user that the infusion device is in a special state.

[0068] According to one aspect of the present invention, the main screen further includes an insulin infusion information graphic display area for displaying insulin infusion information over a period of time in a graphical form.

[0069] According to one aspect of the present invention, in response to a first user input, the insulin infusion information graphic display area displays the insulin infusion information at a specific moment.

[0070] According to one aspect of the present invention, in response to the second user input, the insulin infusion information graphic display area enters the expanded insulin infusion information graphic display area.

[0071] According to one aspect of the present invention, the expanded insulin infusion information graphic display area includes at least a time period selection area and an insulin infusion information graphic display area.

[0072] According to one aspect of the present invention, the expanded insulin infusion information graphic display area further includes an insulin infusion information text display area.

[0073] According to one aspect of the present invention, the insulin infusion information graphic display area further includes an event indication mark for indicating the time when an event occurs.

[0074] According to one aspect of the present invention, the detailed insulin infusion information interface is entered from the insulin infusion information graphic display area through a third user input.

[0075] According to one aspect of the present invention, the thin insulin infusion information interface includes at least basic statistical data.

[0076] According to one aspect of the present invention, in response to the fourth user input, the main screen further includes a time period selection area, for selecting different time periods to view the corresponding insulin infusion information levels within the different time periods.

[0077] According to one aspect of the present invention, in response to a fifth user input, the user enters the detailed insulin infusion information interface from the insulin infusion information graphic display area.

[0078] According to one aspect of the present invention, the detailed insulin infusion information interface includes at least basic statistical data.

[0079] According to one aspect of the present invention, the main screen also includes at least one or more of an icon of the amount of insulin that has not yet taken effect in the body 10B, an icon of the remaining insulin amount, an icon of the last large dose infusion information, and an icon of the remaining time of the infusion device.

[0080] Compared with the prior art, the technical solution of the present invention has the following advantages:

[0081] In the drug infusion system with a graphical user interface disclosed in the present invention, the user interface includes a main screen, which includes an insulin information display area and a blood glucose information display area. The user interface displays insulin infusion status information in the form of graphics and / or text. The graphic is a circle with at least one color, indicating the infusion type and progress of insulin infusion. The text includes an abbreviation of the infusion type and the infusion rate or infusion progress. The user can clearly understand the current insulin infusion type, infusion rate or infusion progress, and confirm the infusion status of the drug.

[0082] Furthermore, when the detection device is in the general detection state, the detection device status display area displays the blood glucose reading at the most recent moment, and displays the blood glucose value in different blood glucose states in different colors. At the same time, arrows of different colors, different numbers, and different directions are used to indicate the changing trend of blood glucose. The blood glucose reading and blood glucose trend indicator arrows are both set in the circle indicating the insulin infusion type and progress. The user can intuitively understand the current insulin infusion status, blood glucose value, and blood glucose change trend at the same time.

[0083] Furthermore, when the detection device is in a special detection state, the detection device status display area displays text information with specific meaning to remind the user that there is an abnormality in the detection device or the blood glucose value detected by the detection device. The user can promptly understand the special state of the detection device and take corresponding measures to change the state of the infusion device.

[0084] Furthermore, the blood glucose graphic display area includes a blood glucose reading curve or discrete points of blood glucose readings over a period of time, as well as a normal blood glucose value area or standard lines for high and low blood glucose values. By comparing the blood glucose readings with the high and low blood glucose values ​​on the graph, the user can intuitively understand the area where the blood glucose value exceeds the normal blood glucose value over the past period of time, as well as the approximate size of the blood glucose change rate.

[0085] Furthermore, the main screen also includes a detection device calibration display area for displaying the progress of the next calibration of the detection device and reminding the user to calibrate the detection device.

[0086] Furthermore, the main screen includes an infusion pause function icon to remind the user that the drug infusion system is currently under the protection of the hypoglycemia infusion pause function or the predicted hypoglycemia infusion pause function.

[0087] Furthermore, the main screen also includes a blood glucose data recovery icon. When the detection device is reconnected due to loss of connection, it reminds the user that the data is being restored. It disappears after the restoration is completed and does not affect the viewing of blood glucose data.

[0088] The disclosed drug infusion system with a graphical user interface includes a main screen, which includes an insulin information display area and a blood glucose information display area. The main screen can be slid to access other interfaces, allowing users to operate them easily and conveniently. The slidability can be customized, providing a good user experience.

[0089] Furthermore, the drug infusion system with a graphical user interface can return to the main interface from other interfaces by sliding. The method of returning to the main interface is related to the method of entering the main screen, which is easy for users to remember.

[0090] Furthermore, the drug infusion system with a graphical user interface can also return the user interface from any interface to the main interface in a unified manner, which simplifies the operation and improves the user experience.

[0091] In the drug infusion system with a graphical user interface disclosed in the present invention, the user interface includes a main screen, which includes an insulin information display area and a blood glucose information display area. The insulin information display area includes insulin infusion status information, and the blood glucose information display area includes a blood glucose graphic display area, which graphically displays the user's blood glucose level in a first time period. Through user input, the graphical user interface displays the user's blood glucose level in other time periods, making it convenient for the user to intuitively understand the current insulin infusion status information and blood glucose information in different time periods.

[0092] Furthermore, in response to different user inputs, blood glucose information within different time periods can be displayed on the main screen or in an extended blood glucose information display area that at least partially covers the main screen in various forms, thereby improving user experience.

[0093] Furthermore, in response to user input, a detailed blood glucose information interface can be entered from the blood glucose graphic display area. The detailed blood glucose information interface includes at least basic statistical data and / or distribution statistical data, so that the user can understand more specific blood glucose information.

[0094] In the drug infusion system with a graphical user interface disclosed in the present invention, the user interface includes a main screen, and the main screen includes insulin infusion status information. The user interface displays the insulin infusion status information in the form of graphics and / or text. The graphics are a circle with at least one color, indicating the infusion type and progress of the insulin infusion. The text includes the abbreviation of the infusion type and the infusion rate or infusion progress. The user can clearly understand the current insulin infusion type, infusion rate or infusion progress, confirm the infusion status of the drug, and facilitate the user to intuitively understand the insulin infusion status information.

[0095] Furthermore, the main screen also includes an insulin infusion information graphic display area, which displays the insulin infusion information over a period of time in the form of a chart, making it easier for users to intuitively understand the insulin infusion status information over the past period of time.

[0096] Furthermore, in response to different user inputs, insulin infusion status information within different time periods can be displayed on the main screen or in an extended insulin infusion status information display area that at least partially covers the main screen. Users can understand insulin infusion information within different time periods in various forms, thereby improving user experience.

[0097] Furthermore, in response to user input, a detailed insulin infusion information interface can be entered from the insulin infusion information display area. The detailed insulin infusion information interface includes at least basic statistical data, which facilitates the user to understand more specific insulin infusion information.

[0098] Furthermore, when the infusion device is in a special state, the insulin infusion state information is displayed as text information with specific meaning to remind the user that the infusion device is in a special state. The user can promptly understand the special state of the infusion device and take corresponding measures to change the state of the detection device.

[0099] Furthermore, the main screen also includes at least one or more of an icon for the amount of insulin that has not yet taken effect in the body, an icon for the remaining amount of insulin, an icon for the last large dose infusion information, and an icon for the remaining time of the infusion device, so that the user can understand more information and ensure the safety of the infusion. BRIEF DESCRIPTION OF THE DRAWINGS

[0100] FIG1 is a schematic diagram showing the relationship between the devices of a drug infusion system with a graphical user interface according to one embodiment of the present invention;

[0101] FIG2 is a schematic diagram of a default home screen of a control device of a drug delivery system with a graphical user interface according to one embodiment of the present invention;

[0102] FIG3 is a schematic diagram of a main screen of a drug infusion system with a graphical user interface according to one embodiment of the present invention when the blood glucose value is a discrete value;

[0103] 4 is a schematic diagram of a main screen of a control device of a drug infusion system with a graphical user interface in a blood glucose data recovery state according to one embodiment of the present invention;

[0104] 5 is a schematic diagram of a main screen of a medication infusion system with a graphical user interface according to one embodiment of the present invention when a hypoglycemia infusion pause function or a predicted hypoglycemia infusion pause function in the medication infusion system is turned on;

[0105] FIG6 is a schematic diagram of an expanded blood glucose graphic display area of ​​a user interface of a medication delivery system with a graphical user interface according to one embodiment of the present invention;

[0106] 7 is a schematic diagram of a main screen of a drug infusion system with a graphical user interface when an alarm event occurs according to one embodiment of the present invention;

[0107] FIG8 is a schematic diagram of a main menu interface of a drug infusion system with a graphical user interface according to one embodiment of the present invention;

[0108] FIG9 is a schematic diagram of a status interface of a drug infusion system with a graphical user interface according to one embodiment of the present invention;

[0109] FIG10 is a schematic diagram of an alarm notification interface of a drug infusion system with a graphical user interface according to one embodiment of the present invention;

[0110] FIG11 is a schematic diagram of a shortcut interface of a drug infusion system with a graphical user interface according to one embodiment of the present invention;

[0111] FIG12 is a schematic diagram of an event indication mark of a drug infusion system with a graphical user interface according to one embodiment of the present invention;

[0112] FIG13 is a schematic diagram of a detailed blood glucose information interface of a drug infusion system with a graphical user interface according to one embodiment of the present invention;

[0113] FIG14 is a schematic diagram of another main screen of a control device of a drug infusion system with a graphical user interface according to another embodiment of the present invention;

[0114] FIG15 is a schematic diagram of a default home screen of a control device of a drug delivery system for displaying drug delivery information according to one embodiment of the present invention;

[0115] FIG16 is a schematic diagram of an expanded insulin infusion information graphic display area of ​​a user interface of a drug infusion system for displaying drug infusion information according to one embodiment of the present invention;

[0116] FIG17 is a schematic diagram of a detailed insulin infusion information interface of a drug infusion system for displaying drug infusion information according to one embodiment of the present invention;

[0117] FIG. 18 is a schematic diagram of another main screen of a control device of a drug infusion system for displaying drug infusion information according to one embodiment of the present invention. DETAILED DESCRIPTION

[0118] As mentioned above, in the infusion device and / or control device of the prior art artificial pancreas, the user cannot intuitively understand the insulin information and / or blood glucose information that needs to be paid attention to, and the user cannot operate independently, resulting in a poor user experience.

[0119] In order to solve this problem, the present invention provides a drug infusion system for displaying drug infusion information. The control device is provided with a graphical user interface, which includes a main screen. The main screen includes insulin infusion status information and / or blood glucose information. The graphical user interface displays the insulin infusion status information in the form of graphics and / or text, so that the user can intuitively understand the insulin infusion status information.

[0120] Various exemplary embodiments of the present invention will now be described in detail with reference to the accompanying drawings. It should be understood that unless otherwise specifically stated, the relative arrangement of components and steps, numerical expressions and numerical values ​​set forth in these embodiments should not be construed as limiting the scope of the present invention.

[0121] In addition, it should be understood that for ease of description, the sizes of the various components shown in the drawings are not necessarily drawn according to actual proportional relationships. For example, the thickness, width, length or distance of certain units may be enlarged relative to other structures.

[0122] The following description of exemplary embodiments is merely illustrative and is not intended to limit the present invention, its application, or use in any sense. Technologies, methods, and apparatus known to those skilled in the art may not be discussed in detail herein, but to the extent applicable, such technologies, methods, and apparatuses should be considered part of this specification.

[0123] It should be noted that like reference numerals and letters denote like items in the following figures, and thus, once an item is defined or described in one figure, it will not need to be further discussed in the subsequent figure descriptions.

[0124] FIG1 is a schematic diagram showing the relationship between the devices of a drug infusion system with a graphical user interface according to an embodiment of the present invention.

[0125] The drug infusion system with a graphical user interface disclosed in the embodiment of the present invention mainly includes a detection device 100 , a control device 101 and an infusion device 102 .

[0126] The detection device 100 is used to continuously detect the user's current blood glucose level. Generally, the detection device 100 is a continuous glucose monitoring (CGM) that can detect the user's current blood glucose level in real time, monitor blood glucose changes, and send the current blood glucose level to the control device 101.

[0127] The control device 101 is used to control the operation of the detection device 100 and the infusion device 102. The control device 101 is a portable electronic device, such as a smartphone, PDM, smart watch, handheld device, etc. The portable electronic device may include: a communication interface for communicating with the detection device, infusion device, and external remote devices; a display and display controller for presenting visual information in the form of graphics and / or text and controlling the presentation of visual information; an input device, such as a mouse, keyboard, touch screen, microphone, etc., for receiving input signals; a memory and a processor, etc. The memory is used to store data, records, instructions, etc., and the processor is used to execute instructions in the memory and control the operation of other components.

[0128] Infusion device 102, such as an insulin pump, includes the necessary mechanical structures for insulin infusion and is controlled by control device 101. Based on insulin infusion instructions issued by control device 101, infusion device 102 delivers the currently required insulin into the user's body. Simultaneously, the infusion status of infusion device 102 is also fed back to control device 101 in real time.

[0129] In one embodiment of the present invention, the detection device 100 and the infusion device 102 are disposed in separate structures. Therefore, they are attached to different locations on the user's skin. In this case, the control device 101 transmits wireless signals to and from the detection device 100 and the infusion device 102 to establish a connection between them.

[0130] In another embodiment of the present invention, the detection device 100 and the infusion device 102 are respectively arranged in the same structure, such as the detection device 100 is integrated in the infusion device 102, and the control device 101 directly transmits wireless signals to the detection device 100 and the infusion device 102 to achieve connection with each other.

[0131] FIG. 2 is a default home screen of a control device according to an embodiment of the present invention.

[0132] In an embodiment of the present invention, the main screen includes a status bar icon area 201, which includes a battery icon 2011 for displaying the remaining battery power status or the charging power status of the control device 101; a time icon 2012 for displaying the current time; an audio icon 2013 for indicating different reminder types, such as audio, vibration, or audio + vibration; a communication icon 2014 with the infusion device 102 for displaying the communication connection status with the infusion device 102; and an alarm icon 2015 for displaying alarms of different priorities.

[0133] The main screen also displays insulin information, specifically including an insulin delivery status icon 202, an icon 10B of the amount of insulin that has not yet taken effect in the body, and an icon 204 of the remaining amount of insulin in the infusion device 102. The insulin delivery status icon 202 includes a graphic 2021 and / or text 2022. The graphic 2021 is a circle of different colors, with different colors representing different infusion types, and the progress of the infusion is expressed by the change of color. The text 2022 displays the abbreviation of the insulin infusion type and the infusion rate or infusion progress. When the circle 2021 is gray, it indicates that the infusion device 102 is not activated; when the circle 2021 is green, it indicates that a basal infusion is in progress; when the circle 2021 is a green circle with a dark green portion, it indicates that a temporary basal infusion is in progress, and the dark green portion indicates the progress of the temporary basal infusion; when the circle 2021 is a blue circle with a dark blue portion, the blue circle indicates a standard large-dose infusion, and the dark blue portion indicates the progress of the infusion; when the circle 2021 is a purple circle with a dark purple portion, the purple circle indicates an extended large-dose infusion, and the dark purple portion indicates the progress of the infusion; when the circle 2021 is red, it indicates that the infusion is paused. Text part 2022 Basal (U / H) 1.00 indicates that the current basal infusion rate is 1.00 U / H; Temp Basal (U / H) 1.00: indicates that the temporary basal has been activated, and the temporary basal rate is 1.00 U / H; Temp Basal (U / H) 1.0085%: indicates that the temporary basal volume has been activated, the temporary basal rate is 1.00 U / H, and it is 85% of the current basal rate; Normal (U) 1.00 / 2.00: indicates that the standard bolus has been activated, 1 U of the standard bolus has been infused, and the total amount of the standard bolus is 2 U; Extended (U) 1.00 / 2.00: indicates that the extended bolus has been activated, 1 U of the extended bolus has been infused, and the total amount of the extended bolus is 2 U; C-Normal (U) 1.00 / 2.00: indicates that the standard bolus in the mixed bolus has been activated, 1 U of the standard bolus has been infused, and the total amount of the standard bolus in the mixed bolus is 2 U; C-Ext. (U) 1.00 / 2.00: indicates that the extended bolus in the mixed bolus has been activated, 1 U of the extended bolus has been infused, and the total amount of the extended bolus in the mixed bolus is 2 U; Suspend time remaining 0:15 indicates that the pause is activated and the basal infusion will automatically resume after 15 minutes. In this embodiment of the present invention, the graphic 221 and the text 222 cooperate to display the current insulin infusion status. The user can clearly understand the current insulin infusion type, infusion rate or infusion progress through the graphic and text, and confirm the infusion status of the drug.In other embodiments of the present invention, the main screen may also display the current insulin infusion status only through the graphic 2021 or the text 2022, and the user may also clearly understand the current insulin infusion type, infusion rate or infusion progress.

[0134] The main screen also displays blood glucose information, which includes a blood glucose graph display area 205 and a detection device 100 status display area 206. When the detection device 100 is in a normal detection state, the display area 206 shows the most recent blood glucose reading. When the blood glucose value is within the normal blood glucose range, the blood glucose reading is displayed in green; when the blood glucose value is below the low blood glucose standard value, the blood glucose reading is displayed in yellow; when the blood glucose value is above the high blood glucose standard value, the blood glucose reading is displayed in red. When the detection device 100 is in a special detection state, the display area 206 displays other text information, such as "Warm-Up", indicating that the detection device 100 is in a warm-up state and the user is requested to continue waiting; "ERR", indicating that the detection device 100 needs to be calibrated in 15 minutes; "BG-", indicating that the detection device 100 needs to be calibrated immediately; ??? , indicating that the detection device 100 has no reading, reminding the user to wait or further check whether the detection device 100 needs to be replaced; LOST, indicating that the signal of the detection device 100 has been lost for at least 10 minutes, reminding the user to reconnect the detection device 100; High, indicating that the blood glucose value detected by the detection device 100 is higher than a certain set threshold, which seriously exceeds the generally recognized high blood glucose standard. For example, the generally recognized high blood glucose standard is 13.3mmol / L (240mg / dL), and the threshold is set to 22.2mmol / L (400mg / dL). dL), reminding the user to take measures to change their blood sugar status; Low, indicating that the blood sugar level detected by the detection device 100 is below a certain set threshold, which is significantly lower than the generally recognized hypoglycemia standard. For example, the generally recognized hypoglycemia standard is 4.4mmol / L (80mg / dL), and the threshold is set to 2.2mmol / L (40mg / dL), reminding the user to take measures to change their blood sugar status; when the blood sugar reading is displayed as an underlined reading, it means that the calibration of the detection device 100 at the time of monitoring has expired, reminding the user that the blood sugar value may be inaccurate. The status display area 206 of the detection device 100 is set within the circle 2021.

[0135] The blood glucose graphical display area 205 includes a blood glucose reading curve or discrete blood glucose reading points 2051 over a period of time, as well as a normal blood glucose value area 2052, allowing users to intuitively understand their blood glucose levels over the past and current time periods. As shown in Figures 2 and 3, the normal blood glucose value area 2052 is a region filled with a certain color. In another embodiment of the present invention, the normal blood glucose value range can be displayed with only the high and low blood glucose standard lines highlighted and / or bolded, allowing users to intuitively understand their blood glucose levels and the approximate magnitude of their blood glucose change rate over the past and current time periods. User input, such as touching and holding or sliding the graphical display area 205, will cause a cursor to appear. When the cursor is moved to a point on the blood glucose reading curve, the blood glucose detection time and reading will be displayed near that point. The reading can also be displayed in different colors, such as green when the reading is within a preset range and red when the reading is outside the preset range. When the cursor moves to a point, indicating that the detection device is in the special detection state described above, text information such as "Warm-Up" and "BG-" will also be displayed near that point, and the meaning of each text is consistent with the above. The blood glucose value information or special test status information is displayed near the point for a certain period of time, such as 1s, 2s, or 5s, and then disappears.

[0136] In one embodiment of the present invention, user input, such as long-pressing the blood glucose graph display area 205, can rotate the blood glucose graph display area 205 horizontally and enlarge the graph display area. Simultaneously, the content of the graph display area is expanded, as shown in FIG6 , to form an expanded blood glucose graph display area 600. The expanded blood glucose graph display area 600 can partially or fully cover the main screen area. Preferably, the expanded blood glucose graph display area 600 fully covers the main screen area, thereby allowing the expanded blood glucose graph display area to more clearly display more content, allowing the user to understand more information. The expanded graph display area 600 includes a time period selection area 601, a blood glucose text display area 602, and a blood glucose graph display area 603. The blood glucose text display area 602 is a display area for the detection device status. By clicking on different time periods in the time period selection area 601, the blood glucose level within the corresponding time period can be viewed. The time period displayed on the horizontal axis of the blood glucose graph display area 603 is consistent with the time period selected in the time period selection area 601. Through user input, such as touching and holding or sliding the blood glucose graphic display area 603, a cursor is generated. When the cursor is moved to a point on the blood glucose reading curve, the blood glucose text display area 602 will display the blood glucose test time and reading. The reading can also be displayed in different colors, such as green when the reading is within a preset range and red when the reading is outside the preset range. Clicking the arrows on both sides of the blood glucose text display area 602 allows users to select different time periods. The blood glucose graphic display area 205 displays the blood glucose reading curve or discrete blood glucose reading points within the corresponding time period. When the cursor is moved to a point on the blood glucose reading curve, the blood glucose text display area 602 will display the blood glucose test time and reading. The reading can also be displayed in different colors, such as green when the reading is within the preset range and red when the reading is outside the preset range. When the cursor is moved to a point, the blood glucose text display area 602 will also display text information such as "Warm-Up" and "BG-" as described above when the detection device is in the special detection state as described above. The meaning of each text is also consistent with the above.

[0137] In another embodiment of the present invention, the expanded blood glucose graphic display area 600 may also not include the blood glucose text display area 602. When the cursor is moved to a certain point on the blood glucose reading curve, the blood glucose value and detection time or special detection status at that moment are displayed near the point, and disappear after a certain period of time, such as 1s, 2s, or 5s. The display method of the blood glucose value and detection time, such as color, and the text meaning of the special detection status are as described above and will not be repeated here.

[0138] When an event occurs, such as a meal, including breakfast, lunch, dinner, and snacks, exercise, or a large-dose infusion, the corresponding event indicator mark, as shown in Figure 12, will be displayed in the blood glucose graphic display area 603, as 604, to indicate the time when the specific event occurred. The user can intuitively understand the events such as meals and exercise that occurred within the specified time period. Since the detection device 100 is constantly performing blood glucose testing, the blood glucose reading curve on the blood glucose graphic display area 603 will be continuously updated, and the event indicator mark 604 will also move with the time update on the horizontal axis of the blood glucose graphic display area 603. When the time of the event exceeds the time period displayed on the horizontal axis of the blood glucose graphic display area 603, the event indicator mark will disappear.

[0139] Through user input, such as clicking or double-clicking the blood glucose graphic display area 603, a detailed blood glucose information interface will be entered. As shown in Figure 13, the detailed blood glucose information interface includes a basic statistical data display area 1301 and a distribution statistical data display area 1302. The basic statistical data display area 1301 includes the minimum, maximum, and average values ​​of the detected blood glucose, as well as the number of hypoglycemic episodes (below 3.1mmol / L / 56mg / dL). The distribution statistical data display area 1302 includes the percentage of blood glucose values ​​within the target blood glucose range, the percentage of blood glucose values ​​above the target blood glucose range, the percentage of blood glucose values ​​within the set hypoglycemic range, and the percentage of blood glucose values ​​below the set hypoglycemic range (below 3.1mmol / L / 56mg / dL).

[0140] In another embodiment of the present invention, user input, such as single-clicking the blood glucose display area 205, will display a time period selection area 2053 on the main screen, as shown in Figure 14. By selecting different time periods, the blood glucose levels within the corresponding time periods can be viewed. The time period displayed on the horizontal axis of the blood glucose graphical display area 205 is consistent with the time period selected in the time period selection area 2053. User input, such as touching and holding or sliding the graphical display area 205, will cause a cursor to appear. When the cursor is moved to a point on the blood glucose reading curve, the blood glucose test time and reading will be displayed near that point. The reading can also be displayed in different colors, such as green when the reading is within a preset range and red when the reading is outside the preset range. Similarly, user input, such as double-clicking the blood glucose graphical display area 205, will enter the detailed blood glucose information interface shown in Figure 13.

[0141] When the testing device 100 is in the normal testing state, the blood glucose information also includes a blood glucose trend display area 207. The blood glucose trend display area 207 is represented by arrows with a certain color, direction, and number. The different colors, directions, and numbers show the trend and speed of the blood glucose reading. For example, a green arrow pointing right indicates a stable blood glucose state, indicating that the user does not need to pay special attention to blood glucose at present; an orange arrow pointing to the upper right indicates that blood glucose is slowly rising; an orange arrow pointing to the lower right indicates that blood glucose is slowly falling, reminding the user to pay attention to further changes in blood glucose; an upward red arrow indicates that blood glucose is rising; a downward red arrow indicates that blood glucose is falling; two upward red arrows indicate that blood glucose is rising rapidly, reminding the user to pay close attention to changes in blood glucose or to start adjusting insulin infusion strategy immediately; two downward red arrows indicate that blood glucose is rapidly falling, reminding the user to take immediate measures to change the current blood glucose state, such as supplementing carbohydrates or administering a large dose. The blood glucose reading 206 and the blood glucose trend indicator arrows 207 are both located within the circle 2021 indicating the type and progress of insulin infusion, allowing the user to intuitively understand the current insulin infusion status, blood glucose value, and blood glucose trend.

[0142] The main screen also includes a calibration display area 208 for the detection device 100. In an embodiment of the present invention, the detection device 100 is a CGM. When the CGM function is turned on, the calibration display area 208 is a water drop-shaped icon, and the amount of water drop fill in different colors indicates how long it will take for the next calibration to be completed. As shown in the calibration display area 208 in Figure 2, the next calibration will be completed in 4-6 hours, that is, the user will complete the CGM calibration in 4-6 hours. In another embodiment of the present invention, the detection device 100 is not a CGM, such as a fingertip blood collection device. In this case, the detection device 100 does not require frequent calibration, so there is no calibration display area 208, and the blood glucose graphic display area 205 is displayed as discrete blood glucose value points, as shown in Figure 3.

[0143] The main screen may also include a blood glucose data recovery icon 209. When the detection device 100 is reconnected due to loss of connection, the blood glucose data takes some time to recover. Therefore, during the blood glucose data recovery period, the blood glucose data recovery icon 209 will appear in the blood glucose graph display area 205, as shown in Figure 4. When the blood glucose data is fully recovered, the blood glucose data recovery icon 209 will disappear.

[0144] The main screen may also include a pause infusion function icon 210. When the hypoglycemia pause infusion function or the predicted hypoglycemia pause infusion function in the drug infusion system is turned on, that is, when the sensor reading of the detection device 100 triggers the pause function, the drug infusion device 102 will perform a safety check and automatically pause the infusion. The pause infusion function icon 210 will be displayed on the main screen, as shown in Figure 2. At this time, the pause infusion function icon 210 is similar to a bright yellow shield with a "√" mark in the shield, reminding the user that the drug infusion system is currently providing a safety protection function; when the hypoglycemia pause infusion function or the predicted hypoglycemia pause infusion function is turned off or temporarily unavailable, the pause infusion function icon 210 on the main screen is similar to a gray shield with an "×" mark in the shield, as shown in Figure 5, reminding the user that the system is temporarily unable to provide the hypoglycemia pause infusion function or the predicted hypoglycemia pause infusion function, and the user is asked to wait for the hypoglycemia pause infusion function or the predicted hypoglycemia pause infusion function to be restored, or to turn on the hypoglycemia pause infusion function or the predicted hypoglycemia pause infusion function. In another embodiment of the present invention, when the hypoglycemia infusion suspension function or the predicted hypoglycemia infusion suspension function is turned off or temporarily unavailable, the infusion suspension function icon 210 may not be displayed on the main screen.

[0145] The main screen may also include an alarm status icon 211. In one embodiment of the present invention, even if some alarms have been manually cleared, but the alarm event has not been resolved, the alarm status icon 211 will still be displayed on the main screen, as shown in FIG7 . For example, if the battery of the infusion device 100 is exhausted, the amount of medicine in the infusion device 100 is 0, that is, the user forgets to inject the medicine, the amount of medicine injected exceeds the total daily insulin amount, hypoglycemia suspends infusion, predicted hypoglycemia suspends infusion, etc., the user is prompted that the alarm event has not been resolved and is reminded to resolve the alarm event.

[0146] In embodiments of the present invention, it is also possible to access other interfaces by swiping on the home screen. Specifically, swiping in different directions can access different interfaces, such as swiping from right to left once to access the main menu interface, as shown in Figure 8; swiping from left to right once to access the status interface, as shown in Figure 9; swiping from top to bottom once to access the alarm notification interface, as shown in Figure 10; and swiping from top to bottom to access the shortcut interface, as shown in Figure 11. The embodiments of the present invention are not limited to the specific swiping method; swiping in different directions, such as up, down, left, right, or diagonal, and / or the number of swipes, as well as the specific interfaces that can be accessed, can be configured based on user preferences. Similarly, swiping can also be used to return to the home screen from other interfaces. The specific swiping method for returning is not specifically limited here and can be configured based on user preferences. Preferably, the method for returning to the home screen is related to the method for entering the home screen, such as swiping in opposite directions but with the same number of swipes, to facilitate user memorization. For example, swiping from left to right once to return to the home screen from the main menu interface, swiping from right to left once to return to the home screen from the status interface, swiping from bottom to top once to return to the home screen from the alarm notification interface, and swiping from top to bottom once to return to the home screen from the shortcut interface. Similarly, you can also return to the home screen by setting the sliding direction to be the same but the number of swipes to be different.

[0147] As shown in FIG8 , the main menu interface may include multiple submenus, such as Bolus, Basal, Reservoir, Sensor, History, Events, and Settings. The specific submenu categories, number, layout on the main menu interface, and icons for each submenu can be configured according to user preferences and are not specifically limited here. Clicking on each submenu interface will enter a different submenu interface.

[0148] As shown in Figure 9, the status interface may include multiple status information, such as infusion information, bolus information, basal information, infusion device 102 information, other status information, etc. The category, quantity, layout of the specific status information in the status interface, and the icon of each status information can all be set according to the user's preferences, without specific restrictions here. Clicking on each status information can enter a different status information interface. In an embodiment of the present invention, the alarm notification interface only displays alarm notifications that are still valid within the current day of use. As shown in Figure 10, the alarm notification includes the time when the alarm occurred and the content of the alarm. The alarm notifications can be arranged in chronological order according to the time when the alarm occurred, such as the latest notification being displayed at the top. The content of the alarm notification and the layout of the alarm notification interface can also be arranged according to the user's preferences, without specific restrictions here.

[0149] As shown in Figure 11, the shortcut interface includes a blood glucose shortcut icon, a calibration shortcut icon, a bolus shortcut icon, an audio selection shortcut icon, a vibration selection shortcut icon, a brightness adjustment shortcut icon, etc. The specific category and number of shortcut icons, the layout of the shortcut icon interface, and the specific icons of each shortcut icon can be set according to the user's preferences and are not specifically limited here. Clicking each shortcut icon will enter a different shortcut interface.

[0150] In an embodiment of the present invention, the user interface can also be set to return to the home screen from any interface by setting a specific method. For example, in one embodiment of the present invention, a touch-sensitive button is provided on the user interface. When the user interface is in any interface other than the home screen, the user can return to the home screen by touching the touch-sensitive button or long pressing the touch-sensitive button. Generally, the touch-sensitive button is provided in the lower half of the user interface, and can also be provided in any part of the user interface according to the user's preference. In another embodiment of the present invention, the home screen can be returned by continuously tapping the user interface two or more times. In yet another embodiment of the present invention, the home screen can be returned by a specific sliding direction and number of times, such as continuously sliding two or more times in any direction to return the user interface from any interface to the home screen, such as when two or more fingers slide simultaneously from the center of the user interface to any two or more directions to return the user interface from any interface to the home screen, or when two or more fingers slide simultaneously from any direction to the center of the user interface to return the user interface from any interface to the home screen, or it can be defined as a single slide in a single direction, such as a single slide in a horizontal direction, a vertical direction, or a diagonal direction to return to the home screen.

[0151] In another embodiment of the present invention, the control device further comprises a physical button, and the user interface returns to the main screen from any interface by pressing the physical button.

[0152] In another embodiment of the present invention, when the detection device 100 is not enabled, the control device 101 only controls the operation of the infusion device 102, and the user interface of the control device 101 only displays information related to insulin infusion. The main screen of the control device 101 when the detection device 100 is not enabled is shown in FIG15 . The main screen includes a status bar icon area 151, which includes a battery icon 1511 for displaying the remaining battery power of the control device 101 or the battery power status during charging; a time icon 1512 for displaying the current time; an audio icon 1513 for indicating different types of reminders, such as audio, vibration, or audio + vibration; a communication icon 1514 with the infusion device 102 for displaying the communication connection status with the infusion device 102; and an alarm icon 1515 for displaying alarms of different priorities.

[0153] The main screen also displays insulin information, including an insulin delivery status icon 152, an icon 153 indicating the amount of insulin remaining in the body (10B), an icon 154 indicating the amount of insulin remaining in the infusion device 102, an icon 155 indicating the last bolus infusion information, including the amount and time of the last bolus infusion, an icon 156 indicating the update of insulin infusion information, and an icon 157 indicating the remaining time of the infusion device 102. It should be noted that, in this embodiment of the present invention, the infusion device 102 includes a reusable pump controller and a disposable drug reservoir patch, so the remaining time icon 157 of the infusion device 102 indicates the remaining time until the disposable drug reservoir patch needs to be replaced.

[0154] The insulin delivery status icon 152 includes a graphic 1521 and / or text 1522. The graphic 1521 is a circle of different colors, representing different infusion types with different colors, and the progress of the infusion is expressed by the color change. The text 1522 displays the abbreviation of the insulin infusion type and the infusion rate or infusion progress. When the circle 1521 is gray, it means that the infusion device 102 is not activated; when the circle 1521 is green, it means that a basal infusion is in progress; when the circle 1521 is a green circle with a dark green portion, it means that a temporary basal infusion is in progress, and the dark green portion indicates the infusion progress of the temporary basal infusion; when the circle 1521 is a blue circle with a dark blue portion, the blue circle indicates a standard bolus infusion, and the dark blue portion indicates the infusion progress; when the circle 1521 is a purple circle with a dark purple portion, the purple circle indicates an extended bolus infusion, and the dark purple portion indicates the infusion progress; when the circle 1521 is red, it means that the infusion is paused. Text section 1522 Basal (U / H) 1.00 indicates that the current basal infusion rate is 1.00 U / H; Temp Basal (U / H) 1.00: indicates that the temporary basal volume has been activated and the temporary basal rate is 1.00 U / H; Temp Basal (U / H) 1.0085%: indicates that the temporary basal volume has been activated, the temporary basal rate is 1.00 U / H, and it is 85% of the current basal rate; Normal (U) 1.00 / 2.00: indicates that the standard bolus has been activated, 1 U of the standard bolus has been infused, and the total amount of the standard bolus is 2 U; Extended (U) 1.00 / 2.00: indicates that the extended bolus has been activated, 1 U of the extended bolus has been infused, and the total amount of the extended bolus is 2 U; C-Normal (U) 1.00 / 2.00: indicates that the standard bolus in the mixed bolus has been activated, 1 U of the standard bolus has been infused, and the total amount of the standard bolus in the mixed bolus is 2 U; C-Ext. (U) 1.00 / 2.00: indicates that the extended bolus in the mixed bolus has been activated, 1 U of the extended bolus has been infused, and the total amount of the extended bolus in the mixed bolus is 2 U; Suspend time remaining 0:15 indicates that the pause has been activated, and the basal infusion will be automatically resumed after 15 minutes. In an embodiment of the present invention, the graphic 1521 and the text 1522 cooperate to jointly display the current insulin infusion status, and the user can clearly understand the current insulin infusion type, infusion rate or infusion progress through the graphic and text at the same time, and confirm the infusion status of the drug. Preferably, this text 1522 is set in the graphic 1521, so that the user interface layout is more reasonable and beautiful, and the user experience is further enhanced. In other embodiments of the present invention, the main screen can also display the current insulin infusion status only through the graphic 2021 or the text 2022, and the user can also clearly understand the current insulin infusion type, infusion rate or infusion progress.It should be noted that the embodiments of the present invention do not limit the specific meanings represented by the shapes and colors of the graphics, and the specific meanings represented by different texts, and users can customize them according to their personal habits or preferences.

[0155] When the infusion device 102 is in a special state, the insulin delivery status icon 152 will be replaced with other prompt text to remind the user that there is an abnormality in the infusion device 102. The user can promptly understand the special state of the infusion device and take appropriate measures to change the state of the infusion device. For example, "Pump Lost" means that the control device 101 has lost the signal from the infusion device 102; "Blockage Detected" means that the infusion device 102 is blocked; "Empty Reservoir" means that there is no insulin remaining in the reservoir; "Reservoir Patch Expired" means that the reservoir patch has expired; "Reservoir Patch Battery Exhausted" means that the battery of the reservoir patch has been exhausted; "Pump Controller Error" means that the pump controller is not working properly.

[0156] The main screen also includes a graphical display area 158 for insulin infusion information. The horizontal axis of this graphical display area 158 represents time, while the vertical axis on one side represents the basal infusion rate and the vertical axis on the other side represents the bolus infusion volume. This graphical display area 158 displays insulin infusion information over a period of time in a graphical format. User input, such as touching and holding or sliding the graphical display area 158, causes a cursor to appear. When the cursor is moved to a point on the curve, the insulin infusion volume and time at that point are displayed near that point, and the display disappears after a certain period of time, such as 1 second, 2 seconds, or 5 seconds.

[0157] In one embodiment of the present invention, through user input, such as long pressing the insulin infusion information graphic display area 158, the insulin infusion information graphic display area 158 can be rotated horizontally and the graphic display area can be enlarged. At the same time, the content of the graphic display area is expanded, as shown in FIG16, showing an expanded insulin infusion information graphic display area 1600. The expanded insulin infusion information graphic display area 1600 can partially cover the main screen area or fully cover the main screen area. Preferably, the expanded insulin infusion information graphic display area 1600 fully covers the main screen area. Therefore, the expanded insulin infusion information graphic display area can more clearly display more content to allow the user to understand more information. The expanded graphical display area 1600 includes a time period selection area 1601, an insulin infusion information text display area 1602, and an insulin infusion information graphical display area 1603. The insulin infusion information text display area 1602 displays the status of the detection device. By clicking on different time periods in the time period selection area 1601, insulin infusion information for the corresponding time period can be viewed. The time period displayed on the horizontal axis of the blood glucose graphical display area 1603 corresponds to the time period selected in the time period selection area 1601. User input, such as touching and holding or sliding the graphical display area 158, will cause a cursor to appear. When the cursor is moved to a point on the curve, the insulin infusion information text display area 1602 displays the amount and time of insulin infusion at that time. When the cursor is moved to a point, indicating that the infusion device is in a special state as described above, the insulin infusion information text display area 1602 will also display text messages such as "Pump Lost" or "Blockage Detected," and the meanings of each text message are consistent with those described above.

[0158] In another embodiment of the present invention, the expanded graphic display area 1600 may not include the insulin infusion information text display area 1602. When the cursor is moved to a certain point on the curve, the amount and time of insulin infusion at that time will be displayed near the point, and will disappear after a certain period of time, such as 1s, 2s, or 5s.

[0159] When an event occurs, such as a meal (including breakfast, lunch, dinner, and snacks), or exercise, a corresponding event indicator will be displayed in the insulin infusion information graphical display area 1603, as 1604, indicating the time when the specific event occurred. The user can intuitively understand the events such as meals and exercise that occurred within the specified time period. Because the infusion device 100 continuously infuses insulin, the insulin infusion curve on the insulin infusion information graphical display area 1603 will continuously update, and the event indicator 1604 will also move as the time on the horizontal axis of the insulin infusion information graphical display area 1603 is updated. When the time of the event exceeds the time period displayed on the horizontal axis of the insulin infusion information graphical display area 1603, the event indicator will disappear.

[0160] User input, such as single-clicking or double-clicking the insulin infusion information graphic display area 1603, will enter the detailed insulin infusion information interface, as shown in FIG17. The detailed insulin infusion information includes basic statistical data, such as the total amount of insulin infused during the current interface time period, the total amount of bolus infused and its percentage of the total infused amount, the total amount of basal infused and its percentage of the total infused amount, the number of stops and / or pauses, and the stop / pause time.

[0161] In another embodiment of the present invention, user input, such as single-clicking the insulin infusion information display area 158, will display a time period selection area 1581 on the main screen, as shown in Figure 18. By selecting different time periods, the insulin infusion information level for each corresponding time period can be viewed. The time period displayed on the horizontal axis of the insulin infusion information graphical display area 158 is consistent with the time period selected in the time period selection area 1581. User input, such as touching and holding or sliding the graphical display area 158, will cause a cursor to appear. When the cursor is moved to a point on the curve, the time and amount of insulin infusion at that moment will be displayed near that point. Similarly, user input, such as double-clicking the insulin infusion information graphical display area 158, will enter the detailed insulin infusion information interface shown in Figure 17.

[0162] In summary, the present invention discloses a drug infusion system with a graphical user interface, including a detection device, an infusion device and a control device. The control device has a graphical user interface. The user interface includes a main screen. The main screen includes an insulin information display area and a blood glucose information display area. The insulin information display area includes insulin infusion status information. The user interface displays the insulin infusion status information in the form of graphics and / or text, so that the user can intuitively understand the current insulin infusion status information and blood glucose information.

[0163] Although some specific embodiments of the present invention have been described in detail by way of example, it should be understood by those skilled in the art that the above examples are for illustration only and are not intended to limit the scope of the present invention. It should be understood by those skilled in the art that modifications may be made to the above embodiments without departing from the scope and spirit of the present invention. The scope of the present invention is defined by the appended claims.

Claims

1. A drug infusion system with a graphical user interface, characterized in that: include: A detection device, the detection device is used to detect the blood sugar level of the user; an infusion device for infusing a drug into a user's body; and A control device, wherein the control device wirelessly communicates with the detection device and the infusion device, the control device controls drug delivery by the infusion device, the control device has a graphical user interface, the graphical user interface includes a main screen, the main screen includes an insulin information display area and a blood glucose information display area, the insulin information display area includes insulin infusion status information, and the graphical user interface displays the insulin infusion status information in a graphical and / or textual manner.

2. The drug infusion system with a graphical user interface according to claim 1, characterized in that The graphic is a circle with at least one color, indicating the infusion type and progress of insulin infusion, and the text includes an abbreviation of the infusion type and the infusion rate or infusion progress.

3. The drug infusion system with a graphical user interface according to claim 2, characterized in that: The blood sugar information display area includes a blood sugar graph display area and the detection device status display area.

4. The drug infusion system with a graphical user interface according to claim 3, characterized in that: The detection device status display area is arranged in the circular ring.

5. The drug infusion system with a graphical user interface according to claim 4, characterized in that: The detection device status display area displays information that the detection device is in a general detection state or a special detection state.

6. The drug infusion system with a graphical user interface according to claim 5, characterized in that: When the detection device is in a normal detection state, the detection device state display area displays the most recent blood sugar reading.

7. The drug infusion system with a graphical user interface according to claim 5, characterized in that: When the detection device is in a special detection state, the detection device state display area displays text information with specific meanings to remind the user that the detection device or the blood sugar value detected by the detection device is abnormal.

8. The drug infusion system with a graphical user interface according to claim 3, wherein: The blood glucose graphic display area includes a blood glucose reading curve or discrete points of blood glucose readings over a period of time, as well as a normal blood glucose value area or standard lines for high and low blood glucose values.

9. The drug infusion system with a graphical user interface according to claim 6, characterized in that: When the detection device is in a general detection state, the detection device state display area further includes a blood glucose trend display area.

10. The drug infusion system with a graphical user interface according to claim 9, characterized in that: The blood sugar trend display area is represented by indicating arrows with different numbers, directions and colors.

11. The drug infusion system with a graphical user interface according to claim 10, characterized in that: The blood sugar trend display area is arranged in the circular ring.

12. The drug infusion system with a graphical user interface according to claim 1, wherein: The main screen also includes a detection device calibration display area.

13. The drug infusion system with a graphical user interface according to claim 12, wherein: The calibration display area changes with time and dynamically displays the calibration status of the detection device.

14. The drug infusion system with a graphical user interface according to claim 1, wherein: The main screen also includes a blood glucose recovery data icon, which appears during the blood glucose data recovery period and disappears after the blood glucose data is fully recovered.

15. The drug infusion system with a graphical user interface according to claim 1, wherein: The main screen also includes an infusion pause function icon for displaying the status of a hypoglycemia infusion pause function or a predicted hypoglycemia infusion pause function in the drug infusion system.

16. The drug infusion system with a graphical user interface according to claim 1, wherein: The home screen also includes an alarm status icon.

17. The drug infusion system with a graphical user interface according to claim 1, wherein: The detection device and the infusion device are respectively arranged in different structures.

18. The drug infusion system with a graphical user interface according to claim 1, wherein: The detection device and the infusion device are respectively arranged in the same structure.

19. A drug infusion system with a graphical user interface, characterized in that: include: A detection device, the detection device is used to detect the blood sugar level of the user; an infusion device for infusing a drug into a user's body; and A control device, wherein the control device wirelessly communicates with the detection device and the infusion device, and the control device controls the drug delivery of the infusion device. The control device has a graphical user interface, and the graphical user interface includes a main screen, and the main screen includes an insulin information display area and a blood glucose information display area. The main screen slides to enter other different interfaces.

20. The drug infusion system with a graphical user interface according to claim 19, wherein: The sliding method includes the sliding direction and / or the sliding times. Sliding in different directions and / or sliding times causes the main screen to enter other different interfaces.

21. The drug infusion system with a graphical user interface according to claim 20, wherein: The graphical user interface returns to the main screen from the other different interfaces by sliding.

22. The drug infusion system with a graphical user interface according to claim 21, wherein: The sliding method for entering other different interfaces is related to the sliding method for returning to the main screen from the other different interfaces.

23. The drug infusion system with a graphical user interface according to claim 22, wherein: The sliding direction of the sliding method for entering the other different interfaces is opposite to the sliding direction of the sliding method for returning to the main screen from the other different interfaces, and the number of sliding times is the same.

24. The drug infusion system with a graphical user interface according to claim 20, wherein: The graphical user interface returns to the home screen from any of the other interfaces in a unified manner.

25. The drug infusion system with a graphical user interface according to claim 24, wherein: A touch-sensitive button is provided on the graphical user interface, and the unified manner is to return to the main screen via the touch-sensitive button.

26. The drug infusion system with a graphical user interface according to claim 24, wherein: The unified manner is to return to the home screen by continuously tapping the graphical user interface.

27. The drug infusion system with a graphical user interface according to claim 24, wherein: The unified method is to return to the home screen in a specific sliding direction and number of times.

28. The drug infusion system with a graphical user interface according to claim 24, wherein: The control device further includes a physical button, and the unified method is to return to the home screen via the physical button.

29. The drug infusion system with a graphical user interface according to claim 19, wherein: The insulin information display area includes insulin infusion status information, information on the amount of insulin that has not yet taken effect in the body IOB, and information on the remaining amount of insulin in the infusion device. The user interface displays the insulin infusion status information in graphical and / or textual form.

30. The drug infusion system with a graphical user interface according to claim 19, wherein: The blood sugar information display area includes a blood sugar graph display area and the detection device status display area.

31. The drug infusion system with a graphical user interface according to claim 30, wherein: The detection device status display area displays information that the detection device is in a general detection state or a special detection state.

32. The drug infusion system with a graphical user interface according to claim 30, wherein: The blood glucose graphic display area includes a blood glucose reading curve or discrete points of blood glucose readings over a period of time, as well as a normal blood glucose value area or standard lines for high and low blood glucose values.

33. The drug infusion system with a graphical user interface according to claim 31, wherein: When the detection device is in a general detection state, the detection device state display area further includes a blood glucose trend display area.

34. The drug infusion system with a graphical user interface according to claim 19, wherein: The main screen also includes a detection device calibration display area.

35. The drug infusion system with a graphical user interface according to claim 19, wherein: The main screen also includes a blood glucose recovery data icon, which appears during the blood glucose data recovery period and disappears after the blood glucose data is fully recovered.

36. The drug infusion system with a graphical user interface according to claim 19, wherein: The main screen also includes an infusion pause function icon for displaying the status of a hypoglycemia infusion pause function or a predicted hypoglycemia infusion pause function in the drug infusion system.

37. The drug infusion system with a graphical user interface according to claim 19, wherein: The home screen also includes an alarm status icon.

38. A drug infusion system with a graphical user interface, characterized in that include: A detection device, the detection device is used to detect the blood sugar level of the user; an infusion device for infusing a drug into a user's body; and A control device, wherein the control device wirelessly communicates with the detection device and the infusion device, the control device controls the drug delivery of the infusion device, and the control device has a graphical user interface, the graphical user interface includes a main screen, the main screen includes an insulin information display area and a blood glucose information display area, the insulin information display area includes insulin infusion status information, and the blood glucose information display area includes a blood glucose graphic display area, which graphically displays the user's blood glucose level in a first time period. Based on user input, the graphical user interface displays the user's blood glucose level in other time periods.

39. The drug infusion system with a graphical user interface according to claim 38, wherein: The blood glucose levels in the other time periods are displayed on the main screen.

40. The drug infusion system with a graphical user interface according to claim 39, wherein: Through the user input, a time period selection area is displayed on the main screen. When a different time period is selected, the blood glucose graph display area displays the blood glucose level within the same time period.

41. The drug infusion system with a graphical user interface according to claim 38, wherein: The blood glucose levels in the other time periods are displayed in the expanded blood glucose graphic display area.

42. The drug infusion system with a graphical user interface according to claim 41, wherein: The expanded blood glucose graph display area at least partially covers the main screen.

43. The drug infusion system with a graphical user interface according to claim 42, wherein: The expanded blood glucose graph display area at least includes a time period selection area and a blood glucose graph display area.

44. The drug infusion system with a graphical user interface according to claim 43, wherein: The expanded blood glucose graphic display area also includes a blood glucose text display area for displaying blood glucose value information or special detection status information at a selected moment.

45. The drug infusion system with a graphical user interface according to claim 40 or 43, characterized in that: In response to another user input, the blood glucose graphic display area displays blood glucose value information or special detection status information at a selected moment.

46. ​​The drug infusion system with a graphical user interface according to claim 43, wherein: The blood glucose graphic display area further includes an event indication mark for indicating the time when an event occurs.

47. The drug infusion system with a graphical user interface according to claim 40 or 43, characterized in that: Through another user input, the detailed blood glucose information interface is entered from the blood glucose graphic display area.

48. The drug infusion system with a graphical user interface according to claim 47, wherein: The detailed blood glucose information interface includes at least basic statistical data and / or distribution statistical data.

49. The drug infusion system with a graphical user interface according to claim 38, wherein The blood sugar information display area also includes a detection device status display area.

50. The drug infusion system with a graphical user interface according to claim 49, wherein: The detection device status display area is used to display information that the detection device is in a general detection state or a special detection state.

51. The drug infusion system with a graphical user interface according to claim 50, wherein: When the detection device is in a normal detection state, the detection device state display area displays the blood glucose reading at the most recent moment.

52. The drug infusion system with a graphical user interface according to claim 50, wherein: When the detection device is in a special detection state, the detection device state display area displays text information with specific meanings to remind the user that there is an abnormality in the detection device or the blood sugar value detected by the detection device.

53. The drug infusion system with a graphical user interface according to any one of claims 49 to 52, characterized in that: The user interface displays insulin infusion status information in a graphical and / or textual manner.

54. The drug infusion system with a graphical user interface according to claim 53, wherein: The graphic is a circle with at least one color, indicating the infusion type and progress of insulin infusion, and the text includes an abbreviation of the infusion type and the infusion rate or infusion progress.

55. The drug infusion system with a graphical user interface according to claim 54, wherein: The detection device status display area is arranged in the circular ring.

56. The drug infusion system with a graphical user interface according to claim 55, wherein: When the detection device is in a general detection state, the detection device state display area further includes a blood glucose trend display area.

57. The drug infusion system with a graphical user interface according to claim 56, wherein: The blood sugar trend display area is represented by indicating arrows with different numbers, directions and colors.

58. A drug infusion system for displaying drug infusion information, characterized in that: include: an infusion device for infusing a drug into a user's body; and A control device that wirelessly communicates with the infusion device, controls drug delivery by the infusion device, and has a graphical user interface. The graphical user interface includes a home screen, the home screen includes insulin infusion status information, and the graphical user interface displays the insulin infusion status information in a graphical and / or textual manner.

59. The drug infusion system for displaying drug infusion information according to claim 58, wherein: The graphic is a circle with at least one color, indicating the infusion type and progress of insulin infusion, and the text includes an abbreviation of the infusion type and the infusion rate or infusion progress.

60. The drug infusion system for displaying drug infusion information according to claim 59, wherein: When the infusion device is in a special state, the insulin infusion state information is displayed as text information with a specific meaning to remind the user that the infusion device is in a special state.

61. The drug infusion system for displaying drug infusion information according to claim 60, characterized in that: The main screen also includes an insulin infusion information graphic display area, which displays insulin infusion information over a period of time in the form of a graph.

62. The drug infusion system for displaying drug infusion information according to claim 61, characterized in that: In response to the first user input, the insulin infusion information graphic display area displays the insulin infusion information at a specific moment.

63. The drug infusion system for displaying drug infusion information according to claim 62, characterized in that: In response to the second user input, the insulin infusion information graphic display area enters the expanded insulin infusion information graphic display area.

64. The drug infusion system for displaying drug infusion information according to claim 63, characterized in that: The expanded insulin infusion information graphic display area at least includes a time period selection area and an insulin infusion information graphic display area.

65. The drug infusion system with a graphical user interface according to claim 64, wherein: The expanded insulin infusion information graphic display area also includes an insulin infusion information text display area.

66. The drug infusion system for displaying drug infusion information according to claim 65, characterized in that: The insulin infusion information graphic display area also includes an event indication mark for indicating the time when an event occurs.

67. The drug infusion system for displaying drug infusion information according to claim 66, characterized in that: Through a third user input, a detailed insulin infusion information interface is entered from the insulin infusion information graphic display area.

68. The drug infusion system for displaying drug infusion information according to claim 67, characterized in that: The detailed insulin infusion information interface includes at least basic statistical data.

69. The drug infusion system for displaying drug infusion information according to claim 61, wherein: In response to the fourth user input, the main screen further includes a time period selection area, for selecting different time periods to view the corresponding insulin infusion information levels within the different time periods.

70. The drug infusion system for displaying drug infusion information according to claim 69, wherein: In response to the fifth user input, the detailed insulin infusion information interface is entered from the insulin infusion information graphic display area.

71. The drug infusion system for displaying drug infusion information according to claim 70, characterized in that: The detailed insulin infusion information interface includes at least basic statistical data.

72. The drug infusion system for displaying drug infusion information according to any one of claims 58 to 71, characterized in that: The main screen also includes at least one or more of an icon of the amount of insulin that has not yet taken effect in the body 10B, an icon of the remaining insulin amount, an icon of the last large dose infusion information, and an icon of the remaining time of the infusion device.

Images